Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

New Approach Being Tested on Peritoneal Mesothelioma Patients

Peritoneal mesothelioma is a form of the rare, asbestos-related cancer that forms in the lining that surrounds the abdominal organs. The illness is generally treated using a combination of surgery, chemotherapy and radiation therapy, and though these treatments can offer extended survival times, the disease eventually returns and is always considered fatal. Now, patients whose disease has returned are submitting to an exciting new treatment protocol being tested by both the National Cancer Institute in Rockville, Maryland and Washington University in St. Louis. The approach uses a therapy known as CAR T-cell therapy that modifies cells within the patient’s own immune system with the goal of helping it fight back against the disease and kill cancer cells.

CAR T-cell therapy is already being tested on pleural mesothelioma patients, and has proven highly effective in the treatment of other forms of cancers. The protocol has proven to be both safe and effective enough that the U.S. Food and Drug Administration as approved it for use in treating pediatric leukemia, and there is significant enthusiasm about its potential in the treatment of asbestos-related cancers as well. The approach will involve extracting T cells from the patients, modifying them and then returning them directly to the local site where the tumor resides. This represents a shift from previous approaches that administered the modified cells systemically. It is hoped that the direct delivery will provide a faster result.

The CAR T-cell treatment provides the ability for mesothelioma patients to be dosed repeatedly without significant cost or side effects. The plan for the National Cancer Institute study is that patients in the study will be treated once a week for three weeks in a row. The study is expected to extend through the end of 2020, and is open to patients diagnosed with peritoneal mesothelioma who are a minimum of four weeks from having received an anti-cancer therapy and who have a minimum life expectancy of three months.

If you are a mesothelioma victim and you would like more information on this study or any other treatment options, contact the Patient Advocates at Mesothelioma.net today at  1-800-692-8608.

Terri Oppenheimer

Terri Oppenheimer is an experienced blog writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of expertise include health, medical research, and law.

Get Your FREE Resources Sent Overnight

  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information

– Or Call –

Site Navigation

Where can I

Get Additional Help?

For over 20 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information

– Or Call –

We are here to help you


If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.

$30 Billion Asbestos Trusts
Get Started